Studies from Chinese Academy of Medical Sciences in the Area of Purpura Published (Associations between coagulation factors and livedoid vasculopathy and the efficacy and safety of rivaroxaban in patients with livedoid vasculopathy: a ...)

Source :: Obesity, Fitness & Wellness Week. February 17, 2024, 4655
Publication Year :: 2024
Abstract: 2024 FEB 17 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on purpura. According to news reporting out of [...]

Subjects :: Testing
Diagnosis
Drug therapy
Risk factors
Dosage and administration
Health aspects
Vasculitis -- Diagnosis -- Risk factors -- Drug therapy
Blood coagulation factors -- Health aspects
Rivaroxaban -- Dosage and administration -- Testing

Tools